Loading clinical trials...

Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial

NCT06922578•Cairo University

View on ClinicalTrials.gov

Summary

The goal of this randomized clinical trial is to evaluate the clinical and radiographic success of pulpotomy using Neoputty MTA vital primary molars diagnosed with symptomatic irreversible pulpitis. The main question it aims to answer is: Will Neoputty MTA pulpotomy have higher clinical and radiographic success in comparison to Endoflas pulpectomy in primary molars with irreversible pulpitis?

Eligibility

Age

4 - 9 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Children with spontaneous pain lasting a few seconds to several hours.
•Pain is intensified by thermal stimulus and persists after its removal.
•Pulp hemorrhage after performing access cavity and deroofing of pulp chamber showing reddish pink healthy pulp tissue.
•Radicular pulp health is verified by achieving hemostasis within six minutes of compression using a cotton pellet with 2% sodium hypochlorite.
•Absence of peri-apical or inter-radicular radiolucency, widening of periodontal ligament space, internal or external root resorption.

Exclusion Criteria

•Unrestorable primary molars.
•Primary molars with uncontrolled pulp hemorrhage or pulp necrosis.
•Medically compromised patients who have systemic disease.
•Uncooperative children who refuse treatment.

Key Dates

Start Date

May 1, 2025

Primary Completion Date

May 1, 2026

Completion Date

June 1, 2026

Last Updated

April 10, 2025

Enrollment

ESTIMATED participants

Conditions

Pulpitis - Irreversible

Interventions

NeoPUTTY MTA pulpotomy

PROCEDURE

Endoflas pulpectomy

PROCEDURE

Contacts

manar motawie el nimr, masters

CONTACT

0201101778899 manar.motawie@dentistry.cu.edu.eg

Professional Practices Regarding Treatment of Non-vital Primary Teeth Among Dental Surgeons in France

NCT07297836

Pulpitis - IrreversiblePulp Necrosis+1 more

View study

RECRUITINGNA

Zinc Oxide Ozonated Olive Oil in LSTR

NCT06854744

Pulpitis - IrreversibleOzone+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 10, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial

Inclusion Criteria

Exclusion Criteria

Professional Practices Regarding Treatment of Non-vital Primary Teeth Among Dental Surgeons in France

Zinc Oxide Ozonated Olive Oil in LSTR

Observational Cross-sectional Study Aiming to Determine the Correlation Between Pulpal Status and IL-8 and Presepsin Levels in the Pulpal Blood.

Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp

Evaluation of Pulpotomy Versus Pulpectomy in Primary Molars With Irreversible Pulpitis or Necrotic Pulp

Effect of Different Apical Actions on Local Inflammatory Mediators and Pain